F. Ortíz-Sanjuán

2.0k total citations
43 papers, 581 citations indexed

About

F. Ortíz-Sanjuán is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, F. Ortíz-Sanjuán has authored 43 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Rheumatology, 17 papers in Pulmonary and Respiratory Medicine and 10 papers in Epidemiology. Recurrent topics in F. Ortíz-Sanjuán's work include Vasculitis and related conditions (13 papers), Urticaria and Related Conditions (8 papers) and Systemic Lupus Erythematosus Research (7 papers). F. Ortíz-Sanjuán is often cited by papers focused on Vasculitis and related conditions (13 papers), Urticaria and Related Conditions (8 papers) and Systemic Lupus Erythematosus Research (7 papers). F. Ortíz-Sanjuán collaborates with scholars based in Spain, United States and Argentina. F. Ortíz-Sanjuán's co-authors include Ricardo Blanco, Miguel Á. González‐Gay, J. Loricera, Marcos A. González‐López, V. Calvo-Río, Javier Rueda‐Gotor, Susana Armesto, J. Mir, Ronald A. Navarro and Miriam Cortés Cerisuelo and has published in prestigious journals such as Journal of Hepatology, Annals of the Rheumatic Diseases and Medicine.

In The Last Decade

F. Ortíz-Sanjuán

34 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Ortíz-Sanjuán Spain 13 301 256 139 121 108 43 581
Y. Schoindre France 10 259 0.9× 239 0.9× 102 0.7× 71 0.6× 120 1.1× 25 733
JC Piette France 10 174 0.6× 403 1.6× 47 0.3× 80 0.7× 59 0.5× 21 624
J.-F. Besancenot France 13 188 0.6× 294 1.1× 58 0.4× 22 0.2× 27 0.3× 47 542
Jack Galliford United Kingdom 19 281 0.9× 125 0.5× 362 2.6× 391 3.2× 43 0.4× 39 1.1k
Takeshi Kuyama Japan 9 233 0.8× 103 0.4× 265 1.9× 208 1.7× 114 1.1× 36 768
J Mooney United Kingdom 7 537 1.8× 357 1.4× 63 0.5× 106 0.9× 8 0.1× 11 730
Elaine C. Tozman United States 10 75 0.2× 306 1.2× 36 0.3× 75 0.6× 36 0.3× 11 492
Berkan Armağan Türkiye 13 165 0.5× 208 0.8× 106 0.8× 70 0.6× 7 0.1× 116 602
Rodolfo Puccini Italy 10 108 0.4× 246 1.0× 104 0.7× 135 1.1× 296 2.7× 19 584
N B Bowley United Kingdom 14 602 2.0× 126 0.5× 482 3.5× 56 0.5× 38 0.4× 21 899

Countries citing papers authored by F. Ortíz-Sanjuán

Since Specialization
Citations

This map shows the geographic impact of F. Ortíz-Sanjuán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Ortíz-Sanjuán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Ortíz-Sanjuán more than expected).

Fields of papers citing papers by F. Ortíz-Sanjuán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Ortíz-Sanjuán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Ortíz-Sanjuán. The network helps show where F. Ortíz-Sanjuán may publish in the future.

Co-authorship network of co-authors of F. Ortíz-Sanjuán

This figure shows the co-authorship network connecting the top 25 collaborators of F. Ortíz-Sanjuán. A scholar is included among the top collaborators of F. Ortíz-Sanjuán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Ortíz-Sanjuán. F. Ortíz-Sanjuán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rúa‐Figueroa, Íñigo, Marina Blanco‐Aparicio, Ricardo Blanco, et al.. (2024). Red flags for clinical suspicion of eosinophilic granulomatosis with polyangiitis (EGPA). European Journal of Internal Medicine. 128. 45–52. 5 indexed citations
2.
Arismendi, Ebymar, Marina Blanco‐Aparicio, Moisés Labrador‐Horrillo, et al.. (2024). Eosinophilic Granulomatosis with Polyangiitis: Clinical Suspicion Red Flags Identification by a Systematic Literature Review and Multidisciplinary Expert Consensus. PA4015–PA4015.
3.
Cortés, J. Ivorra, et al.. (2023). The impact of disease activity on health-related quality of life in patients with systemic lupus erythematosus. Medicina Clínica (English Edition). 160(10). 428–433. 2 indexed citations
4.
Atienza‐Mateo, Belén, C. Fernández-Díaz, Esther F. Vicente‐Rabaneda, et al.. (2023). Abatacept in usual and in non-specific interstitial pneumonia associated with rheumatoid arthritis. European Journal of Internal Medicine. 119. 118–124. 12 indexed citations
5.
Cortés, J. Ivorra, et al.. (2023). The impact of disease activity on health-related quality of life in patients with systemic lupus erythematosus. Medicina Clínica. 160(10). 428–433. 4 indexed citations
6.
Ortíz-Sanjuán, F., Carmen Bárcena, José E. Rodríguez, et al.. (2023). AB0928 USE OF RITUXIMAB IN SYSTEMIC SCLEROSIS PATIENTS WITH PULMONARY AND DIFFUSE CUTANEOUS INVOLVEMENT. A SERIES OF 15 CASES. Annals of the Rheumatic Diseases. 82. 1681–1681.
7.
Galíndez-Agirregoikoa, E., D. Prieto-Peña, J. L. Martín-Varillas, et al.. (2021). Treatment With Tofacitinib in Refractory Psoriatic Arthritis: A National Multicenter Study of the First 87 Patients in Clinical Practice. The Journal of Rheumatology. 48(10). 1552–1558. 7 indexed citations
8.
Prieto-Peña, D., Sara Remuzgo‐Martínez, J. Gonzalo Ocejo‐Vinyals, et al.. (2020). Cranial and extracranial giant cell arteritis share similar HLA-DRB1 association. Seminars in Arthritis and Rheumatism. 50(5). 897–901. 9 indexed citations
9.
Calvo-Río, V., José L. Hernández, F. Ortíz-Sanjuán, et al.. (2016). Relapses in patients with Henoch–Schönlein purpura. Medicine. 95(28). e4217–e4217. 49 indexed citations
10.
Blanco, Ricardo, E. Beltrán, J. Loricera, et al.. (2015). Golimumab in uveitis previously treated with other anti-TNF-alpha drugs: a retrospective study of three cases from a single centre and literature review.. PubMed. 32(6). 864–8. 17 indexed citations
11.
12.
Calvo-Río, V., J. Loricera, Cristina Mata, et al.. (2014). Henoch-Schönlein Purpura in Northern Spain. Medicine. 93(2). 106–113. 93 indexed citations
13.
Ortíz-Sanjuán, F., Ricardo Blanco, José L. Hernández, et al.. (2014). Drug-associated Cutaneous Vasculitis: Study of 239 Patients from a Single Referral Center. The Journal of Rheumatology. 41(11). 2201–2207. 28 indexed citations
14.
Beltrán, E., Ricardo Blanco, Lucía Martínez‐Costa, et al.. (2014). Tocilizumab in uveitis refractory to other biologic drugs: a study of 3 cases and a literature review.. PubMed. 32(4 Suppl 84). S54–7. 35 indexed citations
15.
Loricera, J., V. Calvo-Río, F. Ortíz-Sanjuán, et al.. (2013). The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population. Medicine. 92(6). 331–343. 40 indexed citations
16.
Prieto, M., Ángel Rubín, Eugenia Pareja, et al.. (2008). 227 LONG-TERM RESULTS WITH THE USE OF GRAFTS FROM HBSAG NEGATIVE HBCAB POSITIVE DONORS IN LIVER TRANSPLANTATION. Journal of Hepatology. 48. S93–S93. 1 indexed citations
17.
Aguilera, Victoria, Marta Ponce, Marina Berenguer, et al.. (2007). Utilización de los donantes añosos en pacientes trasplantados por cirrosis por virus C. Revista Española de Enfermedades Digestivas. 99(10). 581–7. 6 indexed citations
18.
Ortíz-Sanjuán, F., et al.. (2007). Absceso hepático amebiano: ¿tratamiento farmacológico o punción-aspiración?. Gastroenterología y Hepatología. 30(7). 399–401. 3 indexed citations
19.
Albalate, Marta, et al.. (2007). [Spanish extrahospitalary hemodialysis centers survey].. PubMed. 27(2). 175–83. 5 indexed citations
20.
Villamil, F, Gary Levy, Gian Luca Grazi, et al.. (2006). Long-Term Outcomes in Liver Transplant Patients With Hepatic C Infection Receiving Tacrolimus or Cyclosporine. Transplantation Proceedings. 38(9). 2964–2967. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Y. Schoindre Breakdown of academic impact, for papers by JC Piette Breakdown of academic impact, for papers by J.-F. Besancenot Breakdown of academic impact, for papers by Jack Galliford Breakdown of academic impact, for papers by Takeshi Kuyama Breakdown of academic impact, for papers by J Mooney Breakdown of academic impact, for papers by Elaine C. Tozman Breakdown of academic impact, for papers by Berkan Armağan Breakdown of academic impact, for papers by Rodolfo Puccini Breakdown of academic impact, for papers by N B Bowley
Rankless by CCL
2026